To clarify the mechanism of activation of PKN and the interaction with target molecules in vivo
To clarify the mechanism of activation of PKN and the interaction with target molecules in vivo
批准号:
15510175
负责人:
MUKAI Hideyuki
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
1.PKN构象探针的构建(1)构建了PKN1与CFP、YFP融合蛋白的表达载体。(2)部分表达载体表达的蛋白YFP/CFP FRET比值较高,且与不饱和脂肪酸和某些去污剂等PKN激活剂的浓度有关。(3)这些重组蛋白在细胞质中定位均一,但与RhoB活性形式共表达时分布于核周和质膜。然而,YFP/CFP FRET比率与非活性形式的RhoB共表达时没有显著差异。这些结果表明,与RhoB的结合不足以引起PKN1.2的活性构象变化。2.构建PKN激活报告基因(Nkar)利用生物素标记的组合肽文库分析PKN的特异性磷酸化基序。结果表明,该磷酸化基序与PKC家族成员的磷酸化基序非常相似。根据PKN和PKC的细微差别,设计了几种合成肽,最终确定了对PKC具有选择性但不被PKN磷酸化的多肽基序。这将有助于改善目前的奥卡尔制度。另一方面,PKN的特异性多肽基序还没有被阐明。我们仍在努力确定PKN的特定底物序列,并希望建立粗提物和NKAR中PKN的检测系统。
英文摘要
1.Construction of NCOP (PKN conformation probe).(1)The various expression vectors for fusion proteins of PKN1 with CFP and YFP were constructed.(2)The YFP/CFP FRET ratios of the proteins produced by some of these vectors were high and were dependent on the concentration of PKN activators such as unsaturated fatty acid and some detergents.(3)The localization of these recombinant proteins were homogeneous in the cytoplasm but were distributed in perinuclear region and plasma membrane when they were co-expressed with the active form of RhoB. However, the YFP/CFP FRET ratios were not significantly different from those when co-expressed with the inactive form of RhoB. These results suggest that the binding with RhoB is not sufficient for the active conformation change of PKN1.2.Construction of NKAR (PKN activation reporter)The specific phosphorylation motif of PKN was analyzed using biotin-tagged combinatorial peptide library. As a result, the phosphorylation motif was very similar to that of PKC family member. Several synthetic peptides were designed based on the information of the subtle difference between PKN and PKC and finally the peptide motif was elucidated which is selective for PKC but is not phosphorylated by PKN. This would help to brush up the present OKAR system. On the other hand, the peptide motif specific for PKN has not been elucidated yet. We are still trying to identify the specific substrate sequence for PKN and would like to setup the assay system for PKN in crude fraction and NKAR.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/mc.20087
发表时间:
2005-05-01
期刊:
MOLECULAR CARCINOGENESIS
影响因子:
4.6
作者:
[Isagawa, T, Takahashi, M, Ono, Y]
通讯作者:
Ono, Y
PKN1ノックアウト動物、および向精神薬開発法
PKN1基因敲除动物及精神药物开发方法
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[]
通讯作者:
Expression and purification of protein kinase C from insect cells
昆虫细胞中蛋白激酶 C 的表达和纯化
DOI:
--
发表时间:
2003
期刊:
Methods Mol.Biol., Protein Kinase C Protocols)(Totowa, NJ)(Humana Press Inc.) 233
影响因子:
--
作者:
[Mukai, H., Ono, Y]
通讯作者:
Y
DOI:
10.1111/j.1365-2443.2005.00816.x
发表时间:
2005-01-01
期刊:
GENES TO CELLS
影响因子:
2.1
作者:
[Nishimura, T, Takahashi, M, Ono, Y]
通讯作者:
Ono, Y
Gotoh Y: "Protein kinase PKN1 associates with TRAF2 and is involved in TRAF2-NF-kappaB signaling pathway"Biochem Biophys Res Commun.. 314(3). 688-694 (2004)
Gotoh Y:“蛋白激酶 PKN1 与 TRAF2 相关并参与 TRAF2-NF-kappaB 信号通路”Biochem Biophys Res Commun. 314(3)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
An analysis of the role of protein kinase PKN3 in the progress of cancer and a development of new anticancer agent
-
批准号:18590294
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.57万
-
财政年份:2006
-
负责人:MUKAI Hideyuki
-
依托单位:
Study on the stress-induced signaling pathway of PKN
-
批准号:09680695
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:MUKAI Hideyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病驱动AGEs积聚进而激活RAGE/DIAPH1/RhoA信号通路促进子宫内膜癌转移的机制研究
-
批准号:JCZRLH202600969
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
西黄丸介导RhOA-ROCK轴重构基质剪切力改善前列腺癌骨转移前龛“瘀毒”微环境的机制研究
-
批准号:2026JJ81061
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吴泳蓉
-
依托单位:
基于RhoA/ROCK2信号通路探讨六味地黄丸调控氧化应激与突触可塑性改善自闭症谱系障碍的机制研究
-
批准号:2026JJ81887
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄婷
-
依托单位:
基于miR-9-5p靶向调控RhoA/ROCK2通路介导神经炎症探讨太极推拿“通督启阳”法干预肌萎缩侧索硬化症的机制研究
-
批准号:JCZRLH202601032
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于H3K18la-RhoA-ROCK轴探索活血通络合剂促进缺血性脑卒中神经功能转归的作用机制
-
批准号:2026JJ80550
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:甘荣
-
依托单位:
靶向HDAC6-RhoA/ROCK 轴调控神经可塑性:改善脑出血后长期神经功能预后的机制与效应研究
-
批准号:2026JJ81723
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭翠英
-
依托单位:
基于“养元通络”理论探讨同源点针刺调控RhoA/ROCK通路抑制坏死性凋亡改善缺血性脑卒中的作用机制
-
批准号:JCZRLH202600705
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RhoA通过FoxG1-cyclinD1促进表皮干细胞增殖的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王凡
-
依托单位:
基于RhoA/ROCK信号通路探讨高原平颗粒调控炎症反应与肺微血管内皮细胞通透性改善高原肺水肿的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:赵斯静
-
依托单位:
m6A修饰介导的PRKACA通过负调控RhoA/ROCK1信号通路影响膀胱癌顺铂耐药性的机制研究
-
批准号:2025JJ70560
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王栋洋
-
依托单位: